Darwin Global Management’s Ambrx Biopharma Inc AMAM Stock Holding History

Darwin Global Management’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-16,688,636	Closed	-$238M	–	17
2023 Q4	$238M	Hold	16,688,636	–	–	46.64%	1
2023 Q3	$192M	Hold	16,688,636	–	–	67.54%	1
2023 Q2	$275M	Buy	16,688,636 +5,384,063	+48%	+$67.7M	44.91%	1
2023 Q1	$101M	Buy	11,304,573 +3,720,084	+49%	+$18.7M	27.58%	3
2022 Q4	$17.2M	Buy	+7,584,489	New	+$8.67M	10.72%	3

Darwin Global Management's AMAM Position: Q1 2024 in Review

Darwin Global Management sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 16,688,636 shares — an estimated $238M sold.

Darwin Global Management first reported a position in AMAM in Q4 2022 and held it in 5 quarters. The position peaked at $275M in Q2 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Darwin Global Management reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Darwin Global Management sold 16,688,636 Ambrx Biopharma Inc shares in Q1 2024, an estimated $238M.
Darwin Global Management first reported a position in Ambrx Biopharma Inc in Q4 2022 and held it in 5 quarters.
Darwin Global Management's Ambrx Biopharma Inc position peaked at $275M in Q2 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Darwin Global Management's 13F filing for Q1 2024, filed 15 May 2024.